Stockholm - Delayed Quote SEK
EQL Pharma AB (EQL.ST)
82.10
-0.40
(-0.48%)
At close: May 9 at 5:29:43 PM GMT+2
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-13,635
-11,437
27,616
41,828
60,047
Investing Cash Flow
-40,410
-66,262
-20,510
-22,090
-55,577
Financing Cash Flow
59,189
53,742
-3,879
-5,118
11,799
End Cash Position
15,557
20,468
44,426
41,199
26,579
Capital Expenditure
-40,409
-66,262
-20,509
-22,090
-55,577
Issuance of Capital Stock
194
266
193
857
0
Issuance of Debt
--
53,970
0
602
12,880
Repayment of Debt
--
-494
-4,073
-6,577
-1,081
Free Cash Flow
-54,044
-77,699
7,107
19,738
4,470
3/31/2021 - 7/4/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CINPHA.ST Cinclus Pharma Holding AB (publ)
9.80
+2.08%
SECARE.ST Swedencare AB (publ)
41.00
+2.50%
MEDXF Medexus Pharmaceuticals Inc.
2.1010
+1.01%
ETST Earth Science Tech, Inc.
0.1500
0.00%
CTX.TO Crescita Therapeutics Inc.
0.5600
0.00%
INNO.CN InnoCan Pharma Corporation
0.1700
-2.86%
CPHRF Cipher Pharmaceuticals Inc.
9.97
-0.20%
CRNO-B.ST Cereno Scientific AB (publ)
8.92
+1.02%
VREOF Vireo Growth Inc.
0.3900
+5.41%
AVNT.TO Avant Brands Inc.
0.8500
0.00%